BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Renovis

Renovis is a science-driven, biopharmaceutical company that seeks to discover, develop and commercialize therapeutics for major medical needs in the areas of neurological and inflammatory diseases. Our goal is to create a sustainable pipeline of first- and best-in-class product candidates that will improve the lives of patients as well as provide superior returns to our investors. We are pursuing this goal by investing strategically in our internal drug discovery activities and by applying our expertise to the selection and acquisition of external programs of equal quality and promise. Over time, we expect this blended approach to yield a balanced portfolio of high-potential product candidates that we can commercialize ourselves or with partners. Our integrated capabilities in small molecule drug discovery, including medicinal chemistry, bioinformatics, molecular biology, and pharmacology, enable us to identify and select drug candidates that meet stringent standards for development. This approach has yielded multiple lead candidates in our preclinical programs for pain and inflammation. Our proprietary preclinical programs are focused on identifying antagonists of selected purinergic receptors as novel potential treatments for a broad spectrum of pain and inflammatory conditions. In addition, we have entered into a collaboration with Pfizer Inc. (Pfizer) to discover and develop product candidates targeting the vanilloid receptor, VR1, for the potential treatment of pain and other diseases and disorders, as well as a collaboration with Genentech, Inc. (Genentech) in the areas of nerve growth and anti-angiogenesis. We currently have more than 60 employees based in South San Francisco, California, who are united in their commitment to translating great science into groundbreaking medicines that improve the lives of patients.


Contact Details:
Two Corporate Drive
South San Francisco
CA
94080-7047
United States of America
Tel:(650) 266 1400
Fax:(650) 266 1460
Email:
WWW:

www.renovis.com/




Loading...

Recent Publications by Renovis:

Technical advances: genome-wide cDNA-AFLP analysis of the Arabidopsis transcriptome.
cDNA-AFLP, a technology historically used to identify small numbers of...
17th March, 2004
Ceres, OMICS. 2003 Summer;7(2):143-59.
Cholinergic and GABAergic pathways in fly motion vision.
BACKGROUND: The fly visual system is a highly ordered brain structure with...
17th April, 2003
Friedrich-Miescher-Laboratorium der Max-Planck-Gesellschaft Spemannstr, BMC Neurosci. 2001;2:1. Epub 2001 Feb 9.

BioNews Results for Renovis:

Bay of Reckoning
San Francisco Magazine:  Sep 11 2008 12:53PM Matching: renovis
Changing medicine: Pfizer exec Corey Goodman launches an experiment that could recreate how Big Pharma makes a
East Bay Business Journal:  Sep 8 2008 4:46AM Matching: renovis
Evotec's partner Pfizer initiates Phase I study of VR1 receptor
Pharmaceutical Business Review:  Aug 2 2008 3:53AM Matching: renovis
Evotec Announces Initiation of Phase I Clinical Trial of VR1 Antagonist under Partnership with Pfizer Inc
Pharma Live:  Aug 1 2008 3:01PM Matching: renovis
Evotec Announces Initiation of Phase I Clinical Trial of VR1 Antagonist Under Partnership With Pfizer Inc
Stockwatch:  Aug 1 2008 6:44AM Matching: renovis
Promote your company here: BioNewsCast - Press Release Distribution

View more Renovis news.

Renovis Patents:

US Patent No.Title
7414131 Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
6759433 Acetamidobenzamide compounds for neurodegenerative disorders
6835754 Use of aryl nitrone compounds in methods for treating neuropathic pain
6998419 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same
7005546 Acetamidobenzamide compounds for neurodegenerative disorders

View more Renovis patents.

Renovis (RNVS) Financial information Links from Barchart

RNVS Quote from from Barchart.com
RNVS Chart from from Barchart.com
RNVS Profile from from Barchart.com
RNVS Opinion from from Barchart.com

View more Renovis finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 204 times since April 2007, the link to the organisation's website has been followed 44 times

Recent Search Terms used to find this page: @renovis.com | renovis.com | @renovis.com | @renovis.com | renovis | .

Search for more companies in South San Francisco

Search for more companies in CA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Renovis
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.